These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 17969354
1. [Clinical trials of ultra-high-dose methylcobalamin in ALS]. Izumi Y, Kaji R. Brain Nerve; 2007 Oct; 59(10):1141-7. PubMed ID: 17969354 [Abstract] [Full Text] [Related]
2. Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis. Ikeda K, Iwasaki Y, Kaji R. J Neurol Sci; 2015 Jul 15; 354(1-2):70-4. PubMed ID: 25982504 [Abstract] [Full Text] [Related]
7. Effect of ultrahigh-dose methylcobalamin on compound muscle action potentials in amyotrophic lateral sclerosis: a double-blind controlled study. Kaji R, Kodama M, Imamura A, Hashida T, Kohara N, Ishizu M, Inui K, Kimura J. Muscle Nerve; 1998 Dec 15; 21(12):1775-8. PubMed ID: 9843082 [Abstract] [Full Text] [Related]
8. Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R, Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. JAMA Neurol; 2022 Jun 01; 79(6):575-583. PubMed ID: 35532908 [Abstract] [Full Text] [Related]
9. Xaliproden in amyotrophic lateral sclerosis: early clinical trials. Lacomblez L, Bensimon G, Douillet P, Doppler V, Salachas F, Meininger V. Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun 01; 5(2):99-106. PubMed ID: 15204011 [Abstract] [Full Text] [Related]
10. Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis. Kaji R, Izumi Y, Oki R. Curr Opin Neurol; 2024 Oct 01; 37(5):593-602. PubMed ID: 39083229 [Abstract] [Full Text] [Related]
12. [What are the etiological medical therapies in amyotrophic lateral sclerosis?]. Dib M. Rev Neurol (Paris); 2006 Jun 01; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114 [Abstract] [Full Text] [Related]